← FDA Drug Approvals (Drugs@FDA)
ARIPIPRAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2024-12-03
Drug application
- FDA Application #
ANDA216608- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ARIPIPRAZOLE
- Generic name
- Aripiprazole
- Active ingredients
- ARIPIPRAZOLE
- Dosage form
- FOR SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Marketing status
- Discontinued
- Sponsor
- MYLAN
- First approval
- 2024-12-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown